Hemostasis Today

November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Olivia C.: Pfizer’s mRNA BNT162b2 Vaccine Does Not Induce High Levels of Inflammation
Mar 26, 2026, 17:14

Olivia C.: Pfizer’s mRNA BNT162b2 Vaccine Does Not Induce High Levels of Inflammation

Olivia C., Business Development Manager at Pfizer, shared a post on LinkedIn:

“Precise data on changes in hematological parameters in vaccinated patients are essential to accurately reflect advancements in medical technology.

Infections can cause significant changes in certain hematological parameters and exacerbate inflammatory responses, such as the neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), platelet-to-lymphocyte ratio (PLR), and ferritin levels.

In contrast, Pfizer’s mRNA-based BNT162b2 vaccine does not induce high levels of inflammation.”

Olivia C.

Stay updated with Hemostasis Today.